2024-05-19
2024-02-08
November 21, 2024
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Asian |
Gender | F |
Age | 65 |
Pathology Diagnosis | Poorly differentiated adenocarcinoma of lung, tumor mass: 4.5 x 4 x 2.5cm. Regional LN: hilum of lung LN (0/1), superior mediastinal LN (3/9), LN of inferior parapulmonary vein (1/1), inferior carina of trachea LN (0/9). IHC results: CK8/18(+),CK7(+++), CK34(+), CK5/6(-), K167(+)10%, CgA(-), HMB45(-), ERCC-1(-), VECFR(++), TP(-), Her-2(+), Syn(-), TTF(++), BGFR(++), B-microtubulin(+++), P53(++), CD34(blood vessel +). |
Biopsy Site | primary |
Treatment History | NA |
Pathology QC | Poorly differentiated adenocarcinoma (P2, P4); IHC (P5): TTF1(+), CDX2(-), CK7(3+), CK20(-). |
Special Features | NA |
Mouse Strain | Balb/c nu |
TMA | TMA-HP-LU-017 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P5 |
Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy